Results 11 to 20 of about 19,127 (154)
Trimethylamine N-oxide in atrial fibrillation progression
The human gut microbiome and its metabolite Trimethylamine N-oxide (TMAO) are sensitive to the human diet and are involved in the complex pathomechanisms that underpin diabetes, obesity, and cardiovascular diseases.
Petra Büttner +7 more
doaj +3 more sources
Role of Trimethylamine N-Oxide in Heart Failure
Heart failure (HF) is a clinical syndrome characterizing by typical physical signs and symptomatology resulting from reduced cardiac output and/or intracardiac pressure at rest or under stress due to structural and/or functional abnormalities of the ...
Lele Jing +6 more
doaj +3 more sources
Trimethylamine N-Oxide: The Good, the Bad and the Unknown [PDF]
Trimethylamine N-oxide (TMAO) is a small colorless amine oxide generated from choline, betaine, and carnitine by gut microbial metabolism. It accumulates in the tissue of marine animals in high concentrations and protects against the protein ...
Manuel T. Velasquez +3 more
doaj +3 more sources
Trimethylamine-N-oxide and cerebral stroke risk: A review
Trimethylamine-N-oxide (TMAO) is a gut microbiota-derived metabolite produced by the action of gut microbiota and the hepatic enzyme Flavin Mono‑oxygenase 3 (FMO3).
Phurbu Dolkar +13 more
doaj +3 more sources
The microbial metabolite trimethylamine N-oxide and the kidney diseases
Trimethylamine N-oxide (TMAO), a metabolite, is a co-metabolite produced by both gut microbiota and livers, originating from foods rich in choline or carnitine.
Jin-Qi Su +15 more
doaj +3 more sources
[Figure: see text]
Adel, Fadi W., Chen, Horng H.
openaire +2 more sources
Trimethylamine N-oxide in cardiovascular disease
Although traditional cardiovascular risk factors are well established and understood, mortality and morbidity in patients with cardiovascular disease (CVD) remains high. Exploring new pathophysiological pathways enables a better understanding of CVD at both the molecular and clinical levels.
Radoslaw Konieczny, Wiktor Kuliczkowski
openaire +2 more sources
Fecal Microbiome Composition Does Not Predict Diet‐Induced TMAO Production in Healthy Adults
Background Trimethylamine‐N‐oxide (TMAO) is a small molecule derived from the metabolism of dietary nutrients by gut microbes and contributes to cardiovascular disease. Plasma TMAO increases following consumption of red meat.
Marc Ferrell +11 more
doaj +1 more source
Background Communication between the gut microbiota and the brain is primarily mediated via soluble microbe-derived metabolites, but the details of this pathway remain poorly defined. Methylamines produced by microbial metabolism of dietary choline and l-
Lesley Hoyles +13 more
doaj +1 more source
Gut Microbiota and Ischemic Stroke: The Role of Trimethylamine N-Oxide [PDF]
Trimethylamine N-oxide (TMAO) is produced when trimethylamine, a waste product of gut microbes, is converted via hepatic flavin monooxygenases. As TMAO is a potential causative factor in various cardiovascular diseases (CVDs) considerable research ...
Hyo Suk Nam
doaj +1 more source

